Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019

Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019

OBJECTIVE: To analyse utilisation patterns of lipid-lowering drugs and the related costs in Switzerland between the years 2013 and 2019. METHODS: We conducted a retrospective descriptive study using administrative claims data of persons aged ≥18 years enrolled with the health insurance company H...

Full description

Bibliographic Details
Main Authors:	Daphne Reinau , Nadine Schur, Sibylle Twerenbold , Eva Blozik , Mathias Früh, Andri Signorell, Matthias Schwenkglenks , Christoph R. Meier
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2021-09-01
Series:	Swiss Medical Weekly
Online Access:	https://www.smw.ch/index.php/smw/article/view/3060

Similar Items

Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data
by: Rahel Schneider, et al.
Published: (2019-09-01)

Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland.
by: Caroline Bähler, et al.
Published: (2016-01-01)

Sun protective behaviour of primary and secondary school students in North-Western Switzerland
by: Daphne Reinau, et al.
Published: (2012-02-01)

Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland
by: Oliver Gruebner, et al.
Published: (2022-05-01)

The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females—Retrospective Study in 2018–2020
by: Yael Rachamin, et al.
Published: (2023-05-01)

Tobacco-related cancer mortality: projections for different geographical regions in Switzerland
by: Verena Jürgens, et al.
Published: (2013-06-01)

Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
by: Verena Jürgens, et al.
Published: (2013-05-01)

Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
by: Agne Ulyte, et al.
Published: (2020-01-01)

The ecology of medical care in Switzerland: prevalence of illness in the community and healthcare utilisation in Switzerland
by: Stéphanie Giezendanner, et al.
Published: (2020-05-01)

Utilisation of information technologies in ambulatory care in Switzerland
by: L Brunner
Published: (2010-09-01)

Perinatal mental disorders in Switzerland: prevalence estimates and use of mental-health services
by: Anke Berger, et al.
Published: (2017-03-01)

Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: an observational study using a large health insurance claims database
by: Stephan Gut, et al.
Published: (2024-02-01)

How does hospitalization affect continuity of drug therapy: an exploratory study
by: Blozik E, et al.
Published: (2016-08-01)

Potentially inappropriate medications and medication combinations before, during and after hospitalizations: an analysis of pathways and determinants in the Swiss healthcare setting
by: Kevin Migliazza, et al.
Published: (2021-05-01)

Coronary and structural heart interventions in Switzerland 2019
by: Max Wagener, et al.
Published: (2021-05-01)

Coronary and structural heart interventions in Switzerland 2018
by: Thomas Nestelberger, et al.
Published: (2020-04-01)

Herpes zoster vaccine: A health economic evaluation for Switzerland
by: Patricia R. Blank, et al.
Published: (2017-07-01)

Primary care emergency services utilisation in German speaking Switzerland
by: U Güntensperger, et al.
Published: (2010-10-01)

General Practitioners’ Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey
by: Sandro Tiziano Stoffel, et al.
Published: (2023-06-01)

Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use-A health insurance claims analysis.
by: Jakob M Burgstaller, et al.
Published: (2020-01-01)

Utilisation of inpatient psychiatric services by people with illicit substance abuse in Switzerland
by: Swiss Medical Weekly
Published: (2006-06-01)

Intensity of treatment in Swiss cancer patients at the end-of-life
by: Bähler C, et al.
Published: (2018-03-01)

Variations of care and diagnosis as markers for the quality of medical care in Switzerland
by: Christoph A. Meier
Published: (2019-02-01)

Factors associated with health-related quality of life among home-dwelling older adults aged 75 or older in Switzerland: a cross-sectional study
by: Flaka Siqeca, et al.
Published: (2022-12-01)

Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data
by: Julia Spoendlin, et al.
Published: (2021-01-01)

Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
by: Landolt S, et al.
Published: (2021-04-01)

Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer
by: Szucs TD, et al.
Published: (2018-04-01)

Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
by: Arjun Bhadhuri, et al.
Published: (2019-12-01)

Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use—A health insurance claims analysis
by: Jakob M. Burgstaller, et al.
Published: (2020-01-01)

Technological, Organizational, and Environmental Factors Influencing Social Media Adoption by Hospitals in Switzerland: Cross-Sectional Study
by: Beier, Michael, et al.
Published: (2020-03-01)

Letter in response to the article published by O. Reich, R. Rapold and M. Flatscher-Thöni. An empirical investigation of the efficiency effects of integrated care models in Switzerland
by: Eva Blozik, et al.
Published: (2012-03-01)

Effects of Integrated Care on Disease-Related Hospitalisation and Healthcare Costs in Patients with Diabetes, Cardiovascular Diseases and Respiratory Illnesses: A Propensity-Matched Cohort Study in Switzerland
by: Carola A. Huber, et al.
Published: (2016-04-01)

Inappropriate use of arthroscopic meniscal surgery in degenerative knee disease: An observational study from Switzerland
by: Leander L S Muheim, et al.
Published: (2017-09-01)

ATHEROSCLEROSIS 2013: CONTROVERSIAL ASPECTS OF LIPID-LOWERING THERAPY IN THE CARDIOLOGIC PRACTICE
by: . . .
Published: (2013-12-01)

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
by: Arjun Bhadhuri, et al.
Published: (2022-06-01)

Trends in Micronutrient Laboratory Testing in Switzerland: A 7-Year Retrospective Analysis of Healthcare Claims Data
by: Huber CA, et al.
Published: (2020-12-01)

Primary care physician supply and other key determinants of health care utilisation: the case of Switzerland
by: Künzi Beat, et al.
Published: (2008-01-01)

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
by: Huber CA, et al.
Published: (2014-10-01)

Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data
by: Eva Gerbier, et al.
Published: (2021-11-01)

Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
by: Leander Muheim, et al.
Published: (2021-04-01)